Rebecca Delconte

Dr Rebecca Delconte is a Group Leader in the department of Cancer Immunology at the Peter MacCallum Cancer Centre. She obtained her PhD from the Walter and Eliza Hall Institute and subsequently completed her postdoc at the Memorial Sloan Kettering Cancer Center. Dr Delconte’s laboratory at the Peter MacCallum focuses on defining the tissue-specific transcriptional, cellular and metabolic processes that promote NK cell anti-tumour function.